Combining ECT with pharmacological treatment of depressed inpatients in a naturalistic study is not associated with serum BDNF level increase
-
Add time:08/30/2019 Source:sciencedirect.com
BackgroundBDNF blood levels are reduced in MDD. They can be increased with pharmacologic treatment and ECT, but it is not clear whether the combination of treatments promotes an additional increase. The present study aims to evaluate whether combined treatment promotes an increase in BDNF, restoring the level to that of non-depressed controls.
We also recommend Trading Suppliers and Manufacturers of ect protein (cas 136111-12-1). Pls Click Website Link as below: cas 136111-12-1 suppliers
Prev:Research reportRemission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF)
Next:Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder09/03/2019
- Psychiatrie biologiqueECT : de la neuroplasticité aux mécanismes d’actionECT : from neuronal plasticity to mechanisms underlying antidepressant medication effect09/02/2019
- Further improving the cognitive effect profile of electroconvulsive therapy (ECT): The case for studying carbamylated erythropoietin☆09/01/2019
- Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only08/31/2019
- Research reportRemission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF)08/29/2019
- Review articleClinical and biological predictors of response to electroconvulsive therapy (ECT): a review08/28/2019
-
Health and Chemical more >